Orthofix Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:OM2 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 May 25	Buy€45,227	Alan Bazaar	Individual	3,990	€11.35
09 May 25	Buy€111,305	Massimo Calafiore	Individual	10,000	€11.13
06 May 25	Buy€7,903,624	Engine Capital Management, LP	Company	523,444	€15.10
16 Apr 25	Sell€44,706	J. Cedron	Individual	3,816	€11.72
09 Apr 25	Buy€6,213,376	Juniper Investment Company, LLC	Company	431,251	€14.57
02 Apr 25	Sell€1,102	Geoffrey Gillespie	Individual	76	€14.50
18 Mar 25	Sell€65,094	Lucas Vitale	Individual	4,287	€15.18
18 Mar 25	Sell€4,494	Geoffrey Gillespie	Individual	296	€15.18
05 Mar 25	Buy€160,377	Massimo Calafiore	Individual	9,914	€16.18
27 Feb 25	Buy€2,909,733	Engine Capital Management, LP	Company	177,483	€16.46
04 Feb 25	Sell€16,410	Geoffrey Gillespie	Individual	954	€17.43
16 Jan 25	Sell€80,896	Julie Andrews	Individual	4,655	€17.38
13 Jan 25	Sell€320,959	Massimo Calafiore	Individual	19,281	€16.81
08 Jan 25	Sell€7,876	Geoffrey Gillespie	Individual	476	€16.63
31 Dec 24	Buy€1,751,040	Juniper Investment Company, LLC	Company	101,089	€18.56
17 Dec 24	Sell€442	Geoffrey Gillespie	Individual	26	€16.99

Insider Trading Volume

Insider Buying: OM2 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OM2?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	571,207	1.46%
General Public	4,167,886	10.6%
Hedge Funds	13,315,117	34%
Institutions	21,126,623	53.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.9%	Engine Capital Management, LP	4,251,671	€46.5m	23.2%	7.18%
9.43%	Rubric Capital Management LP	3,694,946	€40.4m	0%	0.86%
7.82%	BlackRock, Inc.	3,062,197	€33.5m	-0.43%	no data
7.66%	Armistice Capital LLC	3,000,000	€32.8m	-20.4%	0.96%
6.34%	Paradigm Capital Management, Inc.	2,485,900	€27.2m	-2.76%	1.59%
6.05%	Juniper Investment Company, LLC	2,368,500	€25.9m	22.3%	13.04%
5.57%	The Vanguard Group, Inc.	2,181,313	€23.9m	2.56%	no data
3.38%	Emerald Advisers, LLC	1,325,662	€14.5m	-0.04%	0.41%
2.7%	Boone Capital Management LLC	1,057,313	€11.6m	13.6%	4.89%
2.26%	State Street Global Advisors, Inc.	884,850	€9.7m	0.6%	no data
2.21%	Geode Capital Management, LLC	865,464	€9.5m	2.83%	no data
2.07%	Dimensional Fund Advisors LP	812,268	€8.9m	23.2%	no data
1.75%	Soleus Capital Management, L.P.	686,374	€7.5m	13.1%	0.6%
1.54%	Morgan Stanley, Investment Banking and Brokerage Investments	601,439	€6.6m	-56.6%	no data
1.38%	Ayal Capital Advisors Limited	539,871	€5.9m	-17.6%	3.8%
0.92%	AWM Investment Company Inc	360,147	€3.9m	-19.9%	0.57%
0.89%	Northern Trust Global Investments	350,152	€3.8m	-4.87%	no data
0.83%	Charles Schwab Investment Management, Inc.	324,847	€3.6m	-4.32%	no data
0.78%	GAMCO Investors, Inc.	306,100	€3.3m	-1.8%	0.02%
0.59%	Great Lakes Advisors, LLC	229,274	€2.5m	0%	0.02%
0.46%	Clough Capital Partners, LP	180,921	€2.0m	35.7%	0.23%
0.46%	Algert Global LLC	180,303	€2.0m	-1.55%	0.05%
0.46%	Kimberley Elting	179,374	€2.0m	160%	no data
0.44%	Russell Investment Management, LLC	170,573	€1.9m	2.6%	no data
0.43%	Mutual of America Capital Management LLC	169,530	€1.9m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 17:28
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orthofix Medical Inc. is covered by 19 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gregory Chodaczek	Boenning & Scattergood, Inc.
Michael Gorman	BTIG
Caitlin Cronin	Canaccord Genuity